Compare ARK Genomic Revolution ETF (ARKG) vs iShares MSCI United Kingdom (FTSE) (EWU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs iShares MSCI United Kingdom (FTSE) — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while iShares MSCI United Kingdom (FTSE) trades at $46.11. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, iShares MSCI United Kingdom (FTSE) nearer its low. Which is the better fit depends on your goals.
| ARKG | EWU | |
|---|---|---|
Sector | Sector/Thematic | Broad Market / Factor |
52-Week High | $43.57 | $48.68 |
52-Week Low | $23.09 | $39.59 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
EWU trades at $46.60, up 0.41% with a bullish technical signal despite mixed moving averages. The stock shows neutral oscillators and key support at $46. Recent news highlights UK market volatility from political shifts and Middle East tensions affecting the FTSE. A dividend of $0.67 is scheduled for June 2026.
Outlook remains cautious due to UK political instability and economic headwinds, though potential short-squeeze gains offer opportunity. Risks include sterling weakness and global oil price spikes, but institutional interest in undervalued UK assets may support longer-term recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About iShares MSCI United Kingdom (FTSE)
EWU is a country-specific ETF that tracks the performance of the United Kingdom equity market. It provides exposure to large and mid-sized UK companies, with significant weightings in financials, energy, and healthcare, including Shell, AstraZeneca, and HSBC.
Read more on EWU →
